Literature DB >> 32611671

Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study.

Ritch Te Kampe1, Matthijs Janssen2, Caroline van Durme3, Tim L Jansen2, Annelies Boonen4.   

Abstract

OBJECTIVE: Research findings in gout result predominantly from studies about men and might not be generalizable to women. To improve insight into sex differences in gout, our study compared clinical characteristics and comorbidities of female and male patients with gout, and explored the influence of menopause on these differences.
METHODS: Data from patients referred to 2 rheumatology clinics and diagnosed with gout were used. Clinical characteristics and comorbidities of each sex were compared univariately. Sex difference in comorbidities were further explored in multivariate logistic regression analyses adjusting for age, BMI, smoking, and alcohol consumption in both the total group and in those with gout onset ≥ 55 years (as a surrogate for menopausal state).
RESULTS: There were 954 patients, including 793 (83%) men, included. Women were on average older (65 vs 62 yrs), were more often obese (54% vs 36%), had a higher serum uric acid (sUA) level (0.53 vs 0.49 mmol/L), used diuretics more often (60% vs 30%), and consumed alcohol less frequently (47% vs 72%). Additionally, women more frequently had reduced renal function (64% vs 31%), hypertension (78% vs 56%), heart failure (23% vs 12%), and type 2 diabetes (39% vs 17%; all P < 0.05). In those with gout onset ≥ 55 years, differences in comorbidities were less pronounced and disappeared after adjusting for lifestyle.
CONCLUSION: Our study confirmed sex differences in clinical characteristics and comorbidities among newly diagnosed patients with gout, and revealed that sex differences in comorbidities among those with gout onset beyond the age of female menopause were strongly attenuated and fully explained by lifestyle.
Copyright © 2021 by the Journal of Rheumatology.

Entities:  

Keywords:  age of onset; comorbidity; gout; sex; uric acid

Year:  2020        PMID: 32611671     DOI: 10.3899/jrheum.200113

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Impact of adiposity on risk of female gout among those genetically predisposed: sex-specific prospective cohort study findings over >32 years.

Authors:  Natalie McCormick; Chio Yokose; Na Lu; Amit D Joshi; Gary C Curhan; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2021-12-02       Impact factor: 19.103

2.  12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target.

Authors:  Till Uhlig; Lars F Karoliussen; Joseph Sexton; Tove Borgen; Espen A Haavardsholm; Tore K Kvien; Hilde Berner Hammer
Journal:  RMD Open       Date:  2021-03

Review 3.  Managing Gout in Women: Current Perspectives.

Authors:  Aakash V Patel; Angelo L Gaffo
Journal:  J Inflamm Res       Date:  2022-03-03

4.  Racial and Sex Disparities in Gout Prevalence Among US Adults.

Authors:  Natalie McCormick; Na Lu; Chio Yokose; Amit D Joshi; Shanshan Sheehy; Lynn Rosenberg; Erica T Warner; Nicola Dalbeth; Tony R Merriman; Kenneth G Saag; Yuqing Zhang; Hyon K Choi
Journal:  JAMA Netw Open       Date:  2022-08-01

Review 5.  A glance into the future of gout.

Authors:  Francisca Sivera; Mariano Andres; Nicola Dalbeth
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-28       Impact factor: 3.625

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.